Results 121 to 130 of about 3,303,405 (294)

Comparative treatment effects of direct oral anticoagulants versus warfarin for nonvalvular atrial fibrillation in clinical practice vary over time due to channelling

British Journal of Clinical Pharmacology, EarlyView.
Aim Temporal shifts in patient characteristics can influence comparative treatment effects within a certain indication. We investigated patient characteristics and comparative effectiveness and safety for direct oral anticoagulants (DOACs) and warfarin over the time period where DOACs replaced warfarin as preferred stroke prophylaxis in patients with ...
Raoul B. L. J. van den Hemel, Aernoud T. L. Fiolet, Magdalena A. Gamba, Patrick C. Souverein, Olaf H. Klungel, Lourens T. Bloem, Sophie H. Bots   +6 more
wiley   +1 more source

Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 2025

Thrombosis Journal
Introduction Deep Vein Thrombosis is a significant public health concern associated with high morbidity and mortality, mainly when left undiagnosed or untreated.
Sadik Abdulwehab, Frezer Kedir
doaj   +1 more source

Advanced In Vitro Platforms for Experimental Liver Research: From Organoids and Liver‐on‐Chip to Omics and Artificial Intelligence

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Hepatocytes perform essential physiological functions in the human body. Gaining more profound insight into the liver structure, diseases, and physiology by using in vitro models can help to propose more relevant clinical applications. Conventional in vitro liver models, such as two‐dimensional (2D) cell cultures, fail to adequately replicate ...
Seyedeh Kiana Teymorian, Pedram Asadi Sarabi, Abbas Piryaei, Massoud Vosough   +3 more
wiley   +1 more source

Middle cerebral artery occlusion due to paradoxical embolism diagnosed by pulmonary artery thrombosis in the absence of deep vein thrombosis: A case report

Radiology Case Reports
A definitive diagnosis of paradoxical embolism generally requires confirmation of an arterial embolic event, a right-to-left shunt, identification of a venous thrombus, and exclusion of other embolic sources.
Akinobu Ito, MD, Hiroyuki Ikeda, MD, PhD, Masakazu Okawa, MD, PhD, Taichi Ikedo, MD, PhD, Hideo Chihara, MD, PhD, Shigeki Takada, MD, PhD, Noritaka Sano, MD, PhD, Takayuki Kikuchi, MD, PhD, Chiaki Sakai, MD, PhD, Yoshiki Arakawa, MD, PhD   +9 more
doaj   +1 more source

Clinical relevance of distal deep vein thrombosis

, 2008
PURPOSE OF REVIEW: To discuss pros and cons of anticoagulant treatment in the presence of symptomatic distal deep vein thrombosis. RECENT FINDINGS: Available data are responsible for a lack of consensus regarding treatment of distal deep vein thrombosis.
Righini, Marc Philip, Bounameaux, Henri, Righini M, Bounameaux H, Marc Righini, Henri Bounameaux   +5 more
core   +1 more source

Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1

BMEMat, EarlyView.
NP‐SF, designed to target macrophage Dectin‐1 and activated platelets, selectively accumulated in ischemic myocardium, where it was taken up by macrophages after platelet hitchhiking. By inhibiting NLRC5‐related PANoptosis, NP‐SF significantly attenuated pathological damage, and effectively preserved cardiac function in a murine ischemia–reperfusion ...
Guanye Yu, Na Yang, Yan Zhang, Lingxin Peng, Yi Li, Yue Chao, Qinfang Miao, Haikun Qi, Jianhui Zhuang, Weixia Jian, Bingyu Li, Wenhui Peng, Jinghua Chen, Shiyu Gong   +13 more
wiley   +1 more source

Femoral Vein Intravascular Synovial Sarcoma Mimicking Primary Deep Vein Thrombosis—A Rare Cause of Deep Vein Thrombosis

Indian Journal of Radiology and Imaging
Synovial sarcomas are rare malignant mesenchymal soft tissue tumors. We presented the case of a 53-year-old woman patient presenting with acute deep vein thrombosis, later diagnosed as a deep synovial sarcoma of the femoral vein wall.
R. Jayakrishanan, Jineesh Valakkada, Anoop Ayyappan, Rajalakshmi Poyuran, Shivanesan Pitchai   +4 more
doaj   +1 more source

Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

, 2009
R Kreidy1, N Irani-Hakime21Department of Vascular Surgery, 2Department of Laboratory Medicine, Saint George Hospital, University Medical Center, University of Balamand, Beirut, LebanonAim: Factor V Leiden (R506Q) mutation is the most commonly ...
N Irani-Hakime, R Kreidy
core  

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Non-invasive early diagnosis of deep vein thrombosis [PDF]

, 2015
Deep Vein Thrombosis (DVT) is a blood clot that forms in deep veins which commonly occur in lower limb or thigh. The blood clot blocks deep vein and can travel to lung and block pulmonary arteries. This condition will cause fatal Pulmonary Embolism (PE).
Zainal Abidin, Ahmad Noor Ariff
core   +1 more source